Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9

HbE/β-thalassemia is one of the most common thalassemic syndromes in Southeast Asia and Thailand. Patients have mutations in β hemoglobin (HBB) gene resulting in decreased and/or abnormal production of β hemoglobin. Here, we describe a protocol for CRISPR/Cas9-mediated gene correction of the mutated...

Full description

Saved in:
Bibliographic Details
Main Author: Methichit Wattanapanitch
Other Authors: Faculty of Medicine Siriraj Hospital, Mahidol University
Format: Book Chapter
Published: 2022
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/76423
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University